Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders

Research output: Contribution to journalJournal articlepeer-review

  1. Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration

    Research output: Contribution to journalJournal articlepeer-review

  2. Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening

    Research output: Contribution to journalJournal articlepeer-review

  3. VALCOR: a protocol for the validation of SARS-corona virus-2 assays

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

The Danish cervical cancer screening program is a cost-free cancer prevention program for all Danish resident women aged 23-64 years. The coverage is 73%, but screening attendance is slowly declining. Notwithstanding, almost half of all newly diagnosed cervical cancers are found amongst screening non-attenders. To increase screening attendance, the Capital Region of Denmark implemented HPV self-sampling as an alternative offer to women not attending the regular screening offer. This was an opt-in offer to 57,717 screening non-attending women in 2017-2018. They received an invitation letter and could opt-in by letter, phone, e-mail, or website. Invitation and return-of-kit reminders were used in the set-up. HPV positive women were recommended to go to their General Practitioner (GP) for a follow-up sample. HPV negative women returned to the ordinary screening program. Of all invited women, 15,501 opted-in (27%). The purpose designed website was the most frequent used method of response, 63% opted in by the HPV-self sampling website. Use of invitation and return-of-kit reminders generated 8.6% and 6.1% additional responses and participation, respectively, underlining the importance of timely communication. Overall, 17% returned the HPV self-sampling kit for analysis. In addition, 14% had a regular clinician collected screening sample after receiving the invitation for self-sampling, leading to a total screening of 31% of the invited women. HPV prevalence was 15% and 92% of the women positive for HPV adhered to the recommended follow-up.

Original languageEnglish
Article number107096
JournalPreventive Medicine
Volume160
Pages (from-to)1-8
Number of pages8
ISSN0091-7435
DOIs
Publication statusPublished - Jul 2022

Bibliographical note

Copyright © 2021. Published by Elsevier Inc.

    Research areas

  • Cervical cancer screening, HPV self-sampling, Opt-in, Participation

ID: 78238274